Recessive Symptomatic Focal Epilepsy and Mutant Contactin-Associated Protein-like 2
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Contactin-associated protein-like 2 (CASPR2) is encoded by CNTNAP2 and clusters voltage-gated potassium channels (K(v)1.1) at the nodes of Ranvier. We report a homozygous mutation of CNTNAP2 in Old Order Amish children with cortical dysplasia, focal epilepsy, relative macrocephaly, and diminished deep-tendon reflexes. Intractable focal seizures began in early childhood, after which language regression, hyperactivity, impulsive and aggressive behavior, and mental retardation developed in all children. Resective surgery did not prevent the recurrence of seizures. Temporal-lobe specimens showed evidence of abnormalities of neuronal migration and structure, widespread astrogliosis, and reduced expression of CASPR2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this neurodevelopmental phase, Caspr2, the protein encoded by CNTNAP2, is thought to assist in interactions important for cellular migration and subsequent laminar organization, indicating a role for CNTNAP2 in the construction of neural circuits (Strauss et al. 2006).”
From Dysfunctional Autism Risk Genes Cause Circuit-Specific Connectivity Deficits With Distinct Developmental Trajectories (2018) · cites this paper as Strauss et al. 2006
In the citing paper
“Furthermore, temporal lobe sections from human subjects lacking Cntnap2 display abnormal patterns of neuronal migration (Strauss et al., 2006).”
From CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics (2012) · cites this paper as Strauss et al., 2006
In the citing paper
“In the syndromic cases where genetic information was assessed, cases were rarely separated based on presence or absence of ASD or only qualitative neuropathology was provided [128, 340].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [340]
Citations
Cites
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
de Lanerolle, N. C., Kim, J. H., Robbins, R. J., & Spencer, D. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90234-5 · Cited by 927
Kindling and status epilepticus models of epilepsy: rewiring the brain
Morimoto, K., Fahnestock, M., & Racine, R. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.009 · Cited by 838
An astrocytic basis of epilepsy
Tian, G.-F., Azmi, H., Takano, T., Xu, Q., Peng, W., Lin, J., Oberheim, N., Lou, N., Wang, X., Zielke, H. R., et al. (2005) · Nature Medicine · doi:10.1038/nm1277 · Cited by 806
The local differentiation of myelinated axons at nodes of Ranvier
Poliak, S., & Peles, E. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1253 · Cited by 625
Deletion of the KV1.1 Potassium Channel Causes Epilepsy in Mice
Smart, S. L., Lopantsev, V., Zhang, C. L., Robbins, C. A., Wang, H., Chiu, S. Y., Schwartzkroin, P. A., Messing, A., & Tempel, B. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)81018-1 · Cited by 599
Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1
Poliak, S., Salomon, D., Elhanany, H., Sabanay, H., Kiernan, B., Pevny, L., Stewart, C. L., Xu, X., Chiu, S.-Y., Shrager, P., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305018 · Cited by 564
(2000) · Elsevier eBooks · doi:10.1016/b978-0-12-065310-2.x5000-0 · Cited by 472
Zuberi, S. M. (1999) · Brain · doi:10.1093/brain/122.5.817 · Cited by 366
T HE B IOLOGY OF E PILEPSY G ENES
Noebels, J. L. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081210 · Cited by 296
Clinical disorders of brain plasticity
Johnston, M. V. (2004) · Brain and Development · doi:10.1016/s0387-7604(03)00102-5 · Cited by 274
Cited by
Items 101–200 of 657
Puffenberger, E. G., Strauss, K. A., Ramsey, K. E., Craig, D. W., Stephan, D. A., Robinson, D. L., Hendrickson, C. L., Gottlieb, S., Ramsay, D. A., Siu, V. M., et al. (2007) · Brain · doi:10.1093/brain/awm100 · Cited by 125
“Because we work with a young, genetically isolated population (Puffenberger, 2003; Puffenberger et al., 2004; Strauss et al., 2005, 2006), we expected autozygosity mapping would be straightforward.”
BackgroundMethodInfluentialSelf-citationOxytocin modulation of neural circuits for social behavior
Marlin, B. J., & Froemke, R. C. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22452 · Cited by 130
“Mutations in the human gene that encodes contactin-associated protein-like 2 (Cntnap2) result in the presentation of cortical dysplasia and focal epilepsy syndrome, a condition in which 70% of those affected have autism spectrum disorders (Strauss et al., 2006).”
BackgroundEpilepsy surgery for patients with genetic refractory epilepsy: a systematic review
Stevelink, R., Sanders, M. W., Tuinman, M. P., Brilstra, E. H., Koeleman, B. P., Jansen, F. E., & Braun, K. P. (2018) · Epileptic Disorders · doi:10.1684/epd.2018.0959 · Cited by 128
Zebrafish as a Model of Neurodevelopmental Disorders
de Abreu, M. S., Genario, R., Giacomini, A. C. V. V., Demin, K. A., Lakstygal, A. M., Amstislavskaya, T. G., Fontana, B. D., Parker, M. O., & Kalueff, A. V. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.08.034 · Cited by 100
Genome-scale approaches to the epigenetics of common human disease
Feinberg, A. P. (2010) · Virchows Archiv · doi:10.1007/s00428-009-0847-2 · Cited by 126
Regulation of neuronal migration, an emerging topic in autism spectrum disorders
Reiner, O., Karzbrun, E., Kshirsagar, A., & Kaibuchi, K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13403 · Cited by 124
de Jong, J. O., Llapashtica, C., Genestine, M., Strauss, K., Provenzano, F., Sun, Y., Zhu, H., Cortese, G. P., Brundu, F., Brigatti, K. W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24358-4 · Cited by 120
Self-citationSex-specific gene–environment interactions underlying ASD-like behaviors
Schaafsma, S. M., Gagnidze, K., Reyes, A., Norstedt, N., Månsson, K., Francis, K., & Pfaff, D. W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619312114 · Cited by 126
Lazaro, M. T., Taxidis, J., Shuman, T., Bachmutsky, I., Ikrar, T., Santos, R., Marcello, G. M., Mylavarapu, A., Chandra, S., Foreman, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.006 · Cited by 125
Cell migration promotes dynamic cellular interactions to control cerebral cortex morphogenesis
Silva, C. G., Peyre, E., & Nguyen, L. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0148-y · Cited by 135
Risk factors diagnosis prognosis and treatment of autism
Al-Dewik, N. I. E. (2020) · Frontiers in bioscience · doi:10.2741/4873 · Cited by 153
Rapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental Disorder
Parker, W. E., Orlova, K. A., Parker, W. H., Birnbaum, J. F., Krymskaya, V. P., Goncharov, D. A., Baybis, M., Helfferich, J., Okochi, K., Strauss, K. A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005271 · Cited by 120
Self-citationExpanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
Gregor, A., Albrecht, B., Bader, I., Bijlsma, E. K., Ekici, A. B., Engels, H., Hackmann, K., Horn, D., Hoyer, J., Klapecki, J., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-106 · Cited by 121
Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders
Poot, M. (2015) · Molecular Syndromology · doi:10.1159/000371594 · Cited by 125
“Such a truncating mutation has been found in the C-terminal part of CNTNAP2 in a family with children displaying CDFE, mild gross motor delay and frequent seizures, leading to regression of learning abilities and social behavior, such as signs of ADHD and autism [Strauss et al., 2006].”
BackgroundThe genetic basis of Gilles de la Tourette Syndrome
Paschou, P. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.016 · Cited by 130
Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex
Roll, P., Vernes, S. C., Bruneau, N., Cillario, J., Ponsole-Lenfant, M., Massacrier, A., Rudolf, G., Khalife, M., Hirsch, E., Fisher, S. E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq415 · Cited by 114
Peter, B., Raskind, W. H., Matsushita, M., Lisowski, M., Vu, T., Berninger, V. W., Wijsman, E. M., & Brkanac, Z. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9065-0 · Cited by 117
Tan, G. C. Y., Doke, T. F., Ashburner, J., Wood, N. W., & Frackowiak, R. S. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.018 · Cited by 116
Autism spectrum disorders: The quest for genetic syndromes
Zafeiriou, D. I., Ververi, A., Dafoulis, V., Kalyva, E., & Vargiami, E. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32152 · Cited by 107
“, 2006] mutations, among others), cortical dysplasia-focal epilepsy [Strauss et al., 2006], and Dravet [Besag, 2004] syndromes, whereas the latter include amino acidmetabolismdisorders, such as phenylketonuria,”
BackgroundThe functional organization and assembly of the axon initial segment
Ogawa, Y., & Rasband, M. N. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.08.008 · Cited by 127
STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
Orlova, K. A., Parker, W. E., Heuer, G. G., Tsai, V., Yoon, J., Baybis, M., Fenning, R. S., Strauss, K., & Crino, P. B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41592 · Cited by 111
Self-citationThe axon initial segment in nervous system disease and injury
Buffington, S. A., & Rasband, M. N. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07875.x · Cited by 109
“…is one of several autism spectrum disorderlinked genes that is also a genetic risk factor for schizophrenia, and mutations in caspr2 have also been shown to cause epilepsy (Friedman et al., 2008; International Schizophrenia Consortium, 2008; Burbach & van der Zwaag, 2009; Strauss et al., 2006).”
BackgroundBuckley, A. W., & Holmes, G. L. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022749 · Cited by 106
“Homologous mutations of CNTNAP2, which encode contactin-associated protein-like 2, result in cortical dysplasia, focal epilepsy, and macrocephaly (Strauss et al. 2006).”
Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice
Brimberg, L., Mader, S., Jeganathan, V, Berlin, R., Coleman, T. R., Gregersen, P. K., Huerta, P. T., Volpe, B. T., & Diamond, B. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.165 · Cited by 105
Brunner, D., Kabitzke, P., He, D., Cox, K., Thiede, L., Hanania, T., Sabath, E., Alexandrov, V., Saxe, M., Peles, E., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134572 · Cited by 111
“In addition, a homozygous single base pair deletion, resulting in a truncated protein, has been shown to cause Recessive Symptomatic Focal Epilepsy, which presents with autistic symptoms and other characteristics including language regression, cortical dysplasia, epilepsy, macrocephaly, diminished reflexes, hyperactiv…”
BackgroundPharmacological modulation of AMPA receptor rescues social impairments in animal models of autism
Kim, J., Park, K., Kang, R. J., Gonzales, E. L., Kim, D. G., Oh, H. A., Seung, H., Ko, M. J., Kwon, K. J., Kim, K. C., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0098-5 · Cited by 119
“CNTNAP2 is a well-established ASD risk factor, and its mutation is frequently observed in patients with ASD [24, 25].”
BackgroundCurrent Developments in the Genetics of Autism: From Phenome to Genome
Losh, M., Sullivan, P. F., Trembath, D., & Piven, J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318184482d · Cited by 105
“CNTNAP2 was recently associated with autism in a study of an Old Order Amish community that is densely affected with cortical dysplasiafocal epilepsy; the syndrome was associated with autism in 67% of cases (81).”
Whalley, H. C., O’Connell, G., Sussmann, J. E., Peel, A., Stanfield, A. C., Hayiou‐Thomas, M. E., Johnstone, E. C., Lawrie, S. M., McIntosh, A. M., & Hall, J. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31241 · Cited by 116
“…involvement in autism, CNTNAP2 has been implicated in regard to linguistic ability by numerous studies involving both rare and common genetic variation in autistic and non-autistic populations [Strauss et al., 2006; Vernes et al., 2008; Petrin et al., 2010; Poot et al., 2010; Stein et al., 2011].”
BackgroundInfluentialPuffenberger, E. G., Jinks, R. N., Wang, H., Xin, B., Fiorentini, C., Sherman, E. A., Degrazio, D., Shaw, C., Sougnez, C., Cibulskis, K., et al. (2012) · Human Mutation · doi:10.1002/humu.22237 · Cited by 102
“A large proportion of mapped conditions affect brain development [Kelley et al., 2002; Lohr et al., 2010; Puffenberger et al., 2004, 2007; Strauss et al., 2006; Xin et al., 2010].”
BackgroundMethodSelf-citationGenes associated with autism spectrum disorder
Li, X., Zou, H., & Brown, W. T. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.05.017 · Cited by 129
Liska, A., Bertero, A., Gomolka, R., Sabbioni, M., Galbusera, A., Barsotti, N., Panzeri, S., Scattoni, M. L., Pasqualetti, M., & Gozzi, A. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhx022 · Cited by 101
Altered Structural Brain Connectivity in Healthy Carriers of the Autism Risk Gene, CNTNAP2
Dennis, E. L., Jahanshad, N., Rudie, J. D., Brown, J. A., Johnson, K., McMahon, K. L., de Zubicaray, G. I., Montgomery, G., Martin, N. G., Wright, M. J., et al. (2011) · Brain Connectivity · doi:10.1089/brain.2011.0064 · Cited by 101
Mouse Cntnap2 and Human CNTNAP2 ASD Alleles Cell Autonomously Regulate PV+ Cortical Interneurons
Vogt, D., Cho, K. K. A., Shelton, S. M., Paul, A., Huang, Z. J., Sohal, V. S., & Rubenstein, J. L. R. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhx248 · Cited by 96
Neuroimaging in autism—from basic science to translational research
Ecker, C., & Murphy, D. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.276 · Cited by 113
Recent advances in the genetics of language impairment
Newbury, D. F., Fisher, S. E., & Monaco, A. P. (2010) · Genome Medicine · doi:10.1186/gm127 · Cited by 98
Autism spectrum disorders and coexisting disorders in a nationwide Swedish twin study
Lundström, S., Reichenberg, A., Melke, J., Råstam, M., Kerekes, N., Lichtenstein, P., Gillberg, C., & Anckarsäter, H. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12329 · Cited by 90
“…of the major candidate genes for ASD phenotypes, show that rare (Bakkaloglu et al., 2008) and common (Stein et al., 2011 & Vernes et al., 2008) variants are associated with ASD of different severity but also hyperactivity and impulsivity (Strauss et al., 2006) as well as TD (Belloso et al., 2007).”
BackgroundThe genetic basis of thought disorder and language and communication disturbances in schizophrenia
Levy, D. L., Coleman, M. J., Sung, H., Ji, F., Matthysse, S., Mendell, N. R., & Titone, D. (2010) · Journal of Neurolinguistics · doi:10.1016/j.jneuroling.2009.08.003 · Cited by 99
Genetics, Medicine, and the Plain People
Strauss, K. A., & Puffenberger, E. G. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150040 · Cited by 109
Self-citationAssociation of common variants in the Joubert syndrome gene (AHI1) with autism
Alvarez Retuerto, A. I., Cantor, R. M., Gleeson, J. G., Ustaszewska, A., Schackwitz, W. S., Pennacchio, L. A., & Geschwind, D. H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn291 · Cited by 96
“This approach is further supported by recent findings in ASD, in which rare recessive mutations in a gene (CNTNAP2) (30) have been shown to cause a syndromic form of ASD, whereas common variation in the same gene has been shown to contribute to genetic risk for the common, non-syndromic forms of the disorder (31,32).”
BackgroundResultTau Reduction Prevents Key Features of Autism in Mouse Models
Tai, C., Chang, C.-W., Yu, G.-Q., Lopez, I., Yu, X., Wang, X., Guo, W., & Mucke, L. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.038 · Cited by 96
“Loss-of-function mutations in CNTNAP2, which encodes the neurexin family member contactin-associated protein-like 2, cause cortical dysplasia–focal epilepsy syndrome in humans, a condition combining autism with focal seizures (Strauss et al., 2006).”
BackgroundScott, R., Sánchez-Aguilera, A., van Elst, K., Lim, L., Dehorter, N., Bae, S. E., Bartolini, G., Peles, E., Kas, M. J. H., Bruining, H., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhx341 · Cited by 90
“…genetic variation in the CNTNAP2 locus has been associated with childhood apraxia of speech and language impairments, intellectual disability, autism spectrum disorder (ASD), epilepsy, and schizophrenia (Strauss et al. 2006; Friedman et al. 2008; Worthey et al. 2013; Centanni et al. 2015).”
BackgroundResultInfluentialGdalyahu, A., Lazaro, M., Penagarikano, O., Golshani, P., Trachtenberg, J. T., & Gescwind, D. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125633 · Cited by 92
“Together, these data indicate that studying synaptic deficits in other genetic forms of ASD would be valuable.”
BackgroundInfluentialTranslational approaches to the biology of Autism: false dawn or a new era?
Ecker, C., Spooren, W., & Murphy, D. G. M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.102 · Cited by 92
Genetics of Speech and Language Disorders
Kang, C. P., & Drayna, D. T. (2011) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090810-183119 · Cited by 101
The role of interneurons in autism and Tourette Syndrome
Rapanelli, M., Frick, L. R., & Pittenger, C. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.05.004 · Cited by 93
Axon initial segment dysfunction in epilepsy
Wimmer, V. C., Reid, C. A., So, E. Y.-W., Berkovic, S. F., & Petrou, S. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.188417 · Cited by 93
“protein-like 2 (CASPR2) 3709delG (Strauss et al. 2006) Focal epilepsy”
BackgroundDysregulation of Parvalbumin Expression in the Cntnap2−/− Mouse Model of Autism Spectrum Disorder
Lauber, E., Filice, F., & Schwaller, B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00262 · Cited by 104
Syndromic autism: causes and pathogenetic pathways
Benvenuto, A., Moavero, R., Alessandrelli, R., Manzi, B., & Curatolo, P. (2009) · World Journal of Pediatrics · doi:10.1007/s12519-009-0033-2 · Cited by 109
Recent advances in Tourette syndrome
Bloch, M., State, M., & Pittenger, C. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328344648c · Cited by 91
Crino, P. B. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552617 · Cited by 99
Stein, M. B., Yang, B.-Z., Chavira, D. A., Hitchcock, C. A., Sung, S. C., Shipon-Blum, E., & Gelernter, J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.008 · Cited by 89
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript A rare mutation at the contactin-associated protein-like 2 (CNTNAP2) locus was implicated in a syndrome including focal epilepsy, cortical dysplasia, and autism-spectrum-like symptoms in the Old Order Amish (26).”
BackgroundStögmann, E., Reinthaler, E. M., Tawil, S. E., Etribi, M. A. E., Hemeda, M., Nahas, N. M. E., Gaber, A. M., Fouad, A., Edris, S., Benet‐Pagès, A., et al. (2013) · Brain · doi:10.1093/brain/awt068 · Cited by 89
“Mutations in the gene encoding contactin associated protein-like 2 (CNTNAP2) were reported to cause recessive symptomatic focal epilepsy with mental retardation in Old Order Amish People (Strauss et al., 2006).”
BackgroundCorradi, A., Fadda, M., Piton, A., Patry, L., Marte, A., Rossi, P., Cadieux-Dion, M., Gauthier, J., Lapointe, L., Mottron, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt401 · Cited by 86
“Genetic variants in another member of the neurexin superfamily, contactinassociated protein-like 2 (CNTNAP2) have also been associated with ASD (14-17), as well as mutations in two additional synaptic genes, namely IL1RAPL1 and RIMS3/NIM3 (18,19).”
BackgroundSaint‐Martin, M., Joubert, B., Pellier‐Monnin, V., Pascual, O., Noraz, N., & Honnorat, J. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14081 · Cited by 104
“The same mutation was found heterozygous in their parents and four healthy individuals (Strauss et al., 2006).”
Somatic variants in diverse genes leads to a spectrum of focal cortical malformations
Lai, D., Gade, M., Yang, E., Koh, H. Y., Lü, J., Walley, N. M., Buckley, A. F., Sands, T. T., Akman, Ç. I., Mikati, M. A., et al. (2022) · Brain · doi:10.1093/brain/awac117 · Cited by 89
Brown, K. K., Reiss, J. A., Crow, K., Ferguson, H. L., Kelly, C., Fritzsch, B., & Morton, C. C. (2009) · Human Genetics · doi:10.1007/s00439-009-0736-4 · Cited by 87
“dysplasia-focal epilepsy syndrome (Strauss et al. 2006) and other CNTNAP2 variants increase risk for autism (Alarcon”
BackgroundEarly Progenitor Cell Marker Expression Distinguishes Type II From Type I Focal Cortical Dysplasias
Orlova, K. A., Tsai, V., Baybis, M., Heuer, G. G., Sisodiya, S., Thom, M., Strauss, K., Aronica, E., Storm, P. B., & Crino, P. B. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181eac1f5 · Cited by 84
“However, because of the direct link between STRAD> and mTORC1 signaling via the TSC1:TSC2 complex (11), we suggest that the findings in the PS case support our hypothesis that hyperactive mTORC1 signaling is a central feature of type II FCD.”
BackgroundSelf-citationRodenas-Cuadrado, P., Pietrafusa, N., Francavilla, T., La Neve, A., Striano, P., & Vernes, S. C. (2016) · BMC Medical Genetics · doi:10.1186/s12881-016-0272-8 · Cited by 82
“The exon 2–3 deletion (reported herein), exon 3 deletion [16] and c3709delG mutation [14] all produce truncated proteins due to early stop”
BackgroundGenetic causes of developmental disorders
Vorstman, J. A. S., & Ophoff, R. A. (2013) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835f1a30 · Cited by 80
Neural antigen‐specific autoimmune disorders
Iorio, R., & Lennon, V. A. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01144.x · Cited by 86
“Consistent with the emerging theme of autoimmune neurological phenotypes resembling phenotypes of hereditary diseases involving mutations of the corresponding antigenic protein, neurogeneticists recognize LGI1 mutations in patients with a syndrome of autosomal-dominant partial epilepsy and auditory features (105) and…”
BackgroundNodes, paranodes and neuropathies
Fehmi, J., Scherer, S. S., Willison, H. J., & Rinaldi, S. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315480 · Cited by 88
Zerbi, V., Ielacqua, G. D., Markicevic, M., Haberl, M. G., Ellisman, M. H., A-Bhaskaran, A., Frick, A., Rudin, M., & Wenderoth, N. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy046 · Cited by 81
“ating a role for CNTNAP2 in the construction of neural circuits (Strauss et al. 2006).”
BackgroundOxytocin normalizes altered circuit connectivity for social rescue of the Cntnap2 knockout mouse
Choe, K. Y., Bethlehem, R. A. I., Safrin, M., Dong, H., Salman, E., Li, Y., Grinevich, V., Golshani, P., DeNardo, L. A., Peñagarikano, O., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.11.031 · Cited by 85
Yin, J., & Schaaf, C. P. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4942 · Cited by 81
Rea, V., & Raay, T. J. V. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.575575 · Cited by 87
Modeling the functional genomics of autism using human neurons
Konopka, G., Wexler, E., Rosen, E., Mukamel, Z., Osborn, G. E., Chen, L., Lu, D., Gao, F., Gao, K., Lowe, J. K., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.60 · Cited by 78
“In addition, genetic data support common causal etiologies for these disorders in several cases (66–70).”
Belloso, J. M., Bache, I., Guitart, M., Caballín, M. R., Halgren, C., Kirchhoff, M., Ropers, H., Tommerup, N., & Tümer, Z. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201824 · Cited by 82
Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder
García‐Nonell, C., Ratera, E. R., Harris, S., Hessl, D., Ono, M. Y., Tartaglia, N., Marvin, E., Tassone, F., & Hagerman, R. J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32290 · Cited by 76
“Recently, a mutation in the gene encoding the contactin-associated protein-like 2 (CASPR2) was identified as being associated with childhood onset epilepsy and autism in a sample of Old Order Amish children [Strauss et al., 2006].”
BackgroundSavvaki, M., Panagiotaropoulos, T. I., Stamatakis, A., Sargiannidou, I., Karatzioula, P., Watanabe, K., Stylianopoulou, F., Karagogeos, D., & Kleopa, K. A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.025 · Cited by 86
“In pathological material from patients with CASPR2 deficiency (Strauss et al., 2006), abnormalities in neuronal morphology and density were noted, as well as reduced expression of Kv1.”
InfluentialPaternò, R., Marafiga, J. R., Ramsay, H. J., Li, T., Salvati, K. A., & Baraban, S. C. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109970 · Cited by 75
“Indeed, a loss-of-function CNTNAP2 gene mutation was identified in a cohort of ASD patients (Strauss et al., 2006), and CNTNAP2 polymorphism has been associated with an increased risk of ASD (Arking et al., 2008).”
A 12 Mb deletion at 7q33–q35 associated with autism spectrum disorders and primary amenorrhea
Rossi, E. G., Verri, A. P., Patricelli, M. G., Destefani, V., Ricca, I., Vetro, A., Ciccone, R., Giorda, R., Toniolo, D., Maraschio, P., et al. (2008) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2008.06.010 · Cited by 80
TCF4, Schizophrenia, and Pitt-Hopkins Syndrome
Blake, D. J., Forrest, M., Chapman, R. M., Tinsley, C. L., O'Donovan, M. C., & Owen, M. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq035 · Cited by 76
“that include mental retardation, autism, and attentiondeficit hyperactivity disorder.(35) By contrast, heterozygous genomic deletions of CNTNAP2 have been described”
BackgroundXin, B., Puffenberger, E. G., Turben, S., Tan, H., Zhou, A., & Wang, H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908457107 · Cited by 77
Self-citationPinatel, D., Hivert, B., Boucraut, J., Saint‐Martin, M., Rogemond, V., Zoupi, L., Karagogeos, D., Honnorat, J., & Faivre‐Sarrailh, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00265 · Cited by 82
Gene expression studies in autism: Moving from the genome to the transcriptome and beyond
Voineagu, I. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.017 · Cited by 72
“…et al., 2004), TSC1 and TSC2 (tuberous sclerosis) (Wiznitzer, 2004), MECP2 (Rett syndrome) (Amir et al., 1999; Wiznitzer, 2004), CNTNAP2 (cortical dysplasia–focal epilepsy syndrome) (Strauss et al., 2006), DHCR7(Smith–Lemli–Optiz syndrome) (Nowaczyk et al., 2001), FMR1 (Fragile X syndrome).”
Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000002 · Cited by 72
“Copyright @ 2014 President and Fellows of Harvard Colle findings, did identify associations of a handful of genes that continue to be associated with ASD in some studies: those expressed as neuroligins,(53) SHANK,(54) and CNTNAP.(55) The development of array-based technologies to detect relative DNA dosage changes, as…”
BackgroundNeuropathology and Animal Models of Autism: Genetic and Environmental Factors
Gadad, B. S., Hewitson, L., Young, K. A., & German, D. C. (2013) · Autism Research and Treatment · doi:10.1155/2013/731935 · Cited by 33
Mohapatra, A. N., & Wagner, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1205199 · Cited by 80
Xin, B., Puffenberger, E. G., Tumbush, J., Bockoven, J. R., & Wang, H. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31981 · Cited by 71
“The DNA isolation, genotyping, linkage analysis andmutation detectionwereperformed as described previously [Puffenberger et al., 2004; Strauss et al., 2005, 2006].”
MethodSelf-citationvan Coevorden‐Hameete, M. H., de Graaff, E., Titulaer, M. J., Hoogenraad, C. C., & Smitt, P. A. E. S. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.016 · Cited by 78
Tordjman, S., Cohen, D., Anderson, G. M., Botbol, M., Canitano, R., Coulon, N., & Roubertoux, P. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.014 · Cited by 76
Scott, K. E., Schormans, A. L., Pacoli, K. Y., De Oliveira, C., Allman, B. L., & Schmid, S. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0759-18.2018 · Cited by 65
“Homozygous loss-of-function mutations in CNTNAP2 are a rare single gene cause for ASD (Strauss et al., 2006; Poot, 2017) and multiple studies have identified various other CNTNAP2 mutations being associated with, or a risk factor for, ASD and language-related disorders (Alarcón et al.”
BackgroundAnti‐LGI1, anti‐GABABR, and Anti‐CASPR2 encephalitides in Asia: A systematic review
Ghimire, P., Khanal, U. P., Gajurel, B. P., Karn, R., Rajbhandari, R., Paudel, S., Gautam, N., & Ojha, R. (2020) · Brain and Behavior · doi:10.1002/brb3.1793 · Cited by 69
“Studies have shown that mutations in the gene encoding CASPR2 lead to focal epilepsy, mental retardation, schizophrenia, and other neuropsychiatric problems (Friedman et al., 2008; Saint-Martin et al., 2018; Strauss et al., 2006).”
BackgroundBastiaansen, A. E. M., van Sonderen, A., & Titulaer, M. J. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000444 · Cited by 69
Focal cortical dysplasia: an update on diagnosis and treatment
Guerrini, R., & Barba, C. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1915135 · Cited by 54
“FCDs type I and II have also been observed in patients harboring mutations in other genes, including CNTNAP2 [56], SCN1A [57,58], STXBP1 [59], PCDH19 [60], and LGI1 [61],”
BackgroundLahiry, P., Wang, J., Robinson, J. F., Turowec, J. P., Litchfield, D. W., Lanktree, M. B., Gloor, G. B., Puffenberger, E. G., Strauss, K. A., Martens, M. B., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.12.017 · Cited by 75
Self-citationGenetic and cognitive windows into circuit mechanisms of psychiatric disease
Arguello, P. A., & Gogos, J. A. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.007 · Cited by 75
Harkin, L. F., Lindsay, S., Xu, Y., Alzu’bi, A., Ferrara, A., Gullon, E. A., James, O. G., & Clowry, G. J. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw394 · Cited by 79
“In cases of human CNTNAP2 gene mutation, cell migration defects, epilepsy, ASD, and language deficits have all been reported (Strauss et al. 2006; Alarcón et al. 2008; Scott-Van Zeeland et al. 2010).”
BackgroundNew Genes for Focal Epilepsies with Speech and Language Disorders
Turner, S. J., Morgan, A. T., Perez, E. R., & Scheffer, I. E. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0554-0 · Cited by 68
Lu, Z., Reddy, M., Liu, J., Kalichava, A., Liu, J., Zhang, L., Chen, F., Wang, Y., Holthauzen, L. M. F., White, M. A., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.748236 · Cited by 71
“CNTNAP2 also influences the cellular migration of neurons, guiding them to their correct position in the final layered organization of the brain (1, 21, 24).”
BackgroundNuclear and Mitochondrial Genome Defects in Autisms
Smith, M., Spence, M. A., & Flodman, P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03571.x · Cited by 67
Speech and Language: Translating the Genome
Deriziotis, P., & Fisher, S. E. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.07.002 · Cited by 76
Parent-Of-Origin Effects in Autism Identified through Genome-Wide Linkage Analysis of 16,000 SNPs
Fradin, D., Cheslack-Postava, K., Ladd-Acosta, C., Newschaffer, C., Chakravarti, A., Arking, D. E., Feinberg, A., & Fallin, M. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012513 · Cited by 62
“Indeed, this region encompasses the CNTNAP2 gene, a member of the neurexin superfamily, that is significantly associated with autism susceptibility [22,52,53,54], and has shown maternal transmission of risk [22].”
BackgroundFriedman, D., Kannan, K., Faustin, A., Shroff, S., Thomas, C., Heguy, A., Serrano, J., Snuderl, M., & Devinsky, O. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0048-5 · Cited by 61
Toledano, M., & Pittock, S. J. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552625 · Cited by 68
“83,84 In a recent study, investigators incubated rat hippocampi with IgG from a patient with LGI1 positive limbic encephalitis and showed increased afterdischarges upon extracellular stimulation in the stratum lucidum of the CA3 subregion compared with control IgG.”
BackgroundMolecular networks of the FOXP2 transcription factor in the brain
den Hoed, J., Devaraju, K., & Fisher, S. E. (2021) · EMBO Reports · doi:10.15252/embr.202152803 · Cited by 72
Krumbiegel, M., Pasutto, F., Schlötzer-Schrehardt, U. M., Uebe, S., Zenkel, M., Mardin, C. Y., Weisschuh, N., Paoli, D., Gramer, E., Becker, C., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.144 · Cited by 69
Cortical interneuron dysfunction in epilepsy associated with autism spectrum disorders
Jacob, J. (2016) · Epilepsia · doi:10.1111/epi.13272 · Cited by 63
“53 CDFE was originally characterized in a restricted population of Old Order Amish children, who displayed simple partial or complex partial seizure semiology associated with frontotemporal epileptiform EEG abnormalities.(52) However, CNVs involving CNTNAP2 have also been detected in LKS and CSWS, providing an example…”
BackgroundMurdoch, J. D., Gupta, A. R., Sanders, S. J., Walker, M. F., Keaney, J., Fernandez, T. V., Murtha, M. T., Anyanwu, S., Ober, G. T., Raubeson, M. J., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1004852 · Cited by 58
“Moreover, several of the reported human genetic studies have extended the linked or associated phenotype to include language delay [6, 7], intractable epilepsy [1], cortical malformation [1] and intellectual disability [8, 9] (OMIM 610042) and in one instance, hepatomegaly and periventricular leukomalacia [10].”
BackgroundInfluentialEpilepsy with auditory features: A heterogeneous clinico-molecular disease
Pippucci, T., Licchetta, L., Baldassari, S., Palombo, F., Menghi, V., D'Aurizio, R., Leta, C., Stipa, C., Boero, G., d'Orsi, G., et al. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000005 · Cited by 61
Metadata
- Authors
- Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., & Morton, D. H.
- Affiliations
- Clinic for Special Children (US)
- Translational Genomics Research Institute (US)
- Lancaster General Hospital (US)
- Marshfield Clinic Research Foundation (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-03-30
- Volume
- 354
- Issue
- 13
- Pages
- 1370-1377
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2022498096
- Cited by
- 630
- References
- 24
- Citations by year
- 2026: 17 · 2025: 24 · 2024: 17 · 2023: 28 · 2022: 24 · 2021: 25 · 2020: 29 · 2019: 31 · 2018: 37 · 2017: 47 · 2016: 33 · 2015: 45 · 2014: 29 · 2013: 43 · 2012: 47
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- CNTNAP2, nodes of Ranvier, cortical dysplasia, macrocephaly, language regression, intellectual disability, seizure recurrence, resective surgery, astrocyte activation, Old Order Amish
- MeSH terms
- Child, Child, Preschool, Electroencephalography, Epilepsies, Partial, Homozygote, Humans, Membrane Proteins, Mutation, Nerve Tissue Proteins, Phenotype, Reflex, Stretch, Seizures, Temporal Lobe, Gene Expression, Magnetic Resonance Angiography, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.